Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
39
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Innolux
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Embracing eLEAP And Fan-Out PLP Technologies Will Provide Future Advantages Amid Industry Cycles
Key Takeaways Investing in premium, advanced panels and strategic technology collaborations could boost revenue growth and enhance net margins in high-value sectors. Diversifying into high-margin non-commodity markets aims to stabilize earnings and increase profitability by reducing volatility exposure.
View narrative
NT$13.79
FV
10.1% undervalued
intrinsic discount
2.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
CureVac
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
GSK Milestones And Tech Focus Will Shape Oncology Amid Risks
Key Takeaways Strategic focus on innovation and R&D in oncology and infectious diseases positions CureVac for potential high-growth opportunities and revenue enhancement. Strong intellectual property, promising GSK licensing agreements, and a solid cash position bolster competitive edge and future revenue prospects.
View narrative
US$5.35
FV
3.0% overvalued
intrinsic discount
-33.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
17 days ago
author updated this narrative
CytomX Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Late-Stage Trials And Partnerships Will Advance Precision Medicine Despite Setbacks
Key Takeaways Success of clinical candidates and unique tumor-targeting technology could enable regulatory progress, commercial expansion, and attract additional partnerships and licensing agreements. Increasing global cancer rates and strategic industry collaborations support diversified revenue streams, improved cash flow, and long-term growth opportunities.
View narrative
US$5.75
FV
69.4% undervalued
intrinsic discount
-31.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
Bankwell Financial Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Technology Investments And SBA Expansion Will Advance Community Banking
Key Takeaways Expansion of deposit teams and digital efficiencies are strengthening growth, reducing funding costs, and improving profitability while broadening market reach. Enhanced SBA lending, better asset quality, and favorable market dynamics are diversifying income streams and supporting sustainable long-term revenue growth.
View narrative
US$45.00
FV
9.1% undervalued
intrinsic discount
28.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Holcim
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Aggressive Projections Will Falter Amid Regulatory And Market Risks
Key Takeaways High expectations for demand growth and margin expansion may be difficult to meet if market, regulatory, or competitive conditions shift unfavorably. Risks around regulatory costs, disruptive new materials, and integration of acquisitions could undermine profitability and long-term growth assumptions.
View narrative
CHF 65.77
FV
2.8% overvalued
intrinsic discount
-11.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
1 day ago
author updated this narrative
Life Healthcare Group Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Rising Regulatory Burdens And Costs Will Shrink South African Demand
Key Takeaways Long-term revenue growth is threatened by shifts to outpatient care, rising labor costs, and regulatory pressures constraining pricing power and margins. Structural economic and affordability barriers, along with high fixed costs, may limit patient volumes and dampen returns on investment.
View narrative
R12.30
FV
11.8% overvalued
intrinsic discount
2.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Tokmanni Group Oyj
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
E-commerce Surge Will Undercut Brick-And-Mortar Margins Despite Integration Gains
Key Takeaways Heavy dependence on physical stores and a concentrated Finnish presence heighten vulnerability to e-commerce, demographic shifts, and regional economic risks. Persistent cost pressures, rising competition, and a volatile low-margin model threaten margins and limit sustainable long-term growth opportunities.
View narrative
€8.20
FV
2.7% overvalued
intrinsic discount
4.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
FTC Solar
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Global Solar Demand Will Encourage Tracker Adoption
Key Takeaways Proprietary tracker technology and upgraded software drive efficiency, higher margins, and recurring digital revenue for sustainable growth and earnings stability. Global expansion, a strengthened balance sheet, and solar market tailwinds diversify revenue streams and position the company for accelerated long-term profitability.
View narrative
US$5.20
FV
7.9% undervalued
intrinsic discount
74.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
about 9 hours ago
author updated this narrative
LifeStance Health Group
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Telehealth And Digital Tools Will Expand Mental Health Access
Key Takeaways Operational efficiencies and digital advancements could drive substantial improvements in margins, cash flow conversion, and overall financial resilience above industry norms. Growing demand and expansion into higher-margin services position the company for sustainable, diversified long-term revenue growth and earnings stability.
View narrative
US$10.00
FV
44.2% undervalued
intrinsic discount
16.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
Value any company in seconds
Popular companies